Experience

• 

  Andersen consulting

  Aug 1996 - Sept 2002

  Manager, financial services – audit & consulting

  As key account manager for major Global companies (Goldman Sachs, State Street Bank, Rothschild Bank, …), performed the process of independent evaluation of these company's financial statements.­Recognized expert in the Luxembourg Financial Services industry (Banking, Asset Management & Hedge Funds). Designed, implemented and trained external audit methodology as well as led a companywide knowledge group.

• 

  Arcelor mittal

  Oct 2002 - Oct 2005

  Senior manager, head of risk management & internal audit

  Set-up the local department and delivered audit assignments. Identified critical business risks and implemented mitigation actions. ­Defined corporate internal audit procedures (operations, environment, health & safety, sales, finance, HR, logistics, purchases, insurances …) and delivered strategic initiatives (acquisition projects, plant transfer, transfer price model evaluation, working capital, compliance with IAS, forex hedging, due diligence on sales, logistics & purchasing …).

• 

  Glaxosmithkline biologicals

  Jun 2006 - Feb 2016

  ­Optimized the end-to-end value chain by matching product/technology portfolio evolution, supply capacity & demand for medium to long term, in a cost-effective manner & by maximizing asset utilization. Defined the manufacturing strategy, led strategic recommendations on major capital investments and drove execution across multi-sites (15+), enabling sales of £1 billion per year. Delivered a Transformation program supporting commercial ambition: enhanced Project Management best practices, Operational Excellence principles as well as Organisational Development skills. Delivered global market sales optimization vs available capacity while ensuring consistency with budgets, by fostering mindset shift from “sales” to “profitable growth”, with full P&L accountability. Enhanced collaboration between global Manufacturing, Finance, IT, Commercial and local business units.Forecasting accuracy was significantly improved and robust production plans were implemented to achieve £3 bio annual sales. ­

  • Director Strategy & Product (Paediatric Vaccines)

    Jan 2012 - Feb 2016

  • Director Paediatric Vaccines Supply Chain

    Mar 2010 - Jan 2012

  • Director, Head of Global Sales & Operations Planning

    Jun 2006 - Feb 2010
• 

  Cj global consulting srl

  Apr 2016 - now

  Ceo | senior consultant

  Since 2016, through my own legal structure, I am also acting as Senior Executive Consultant and have delivered several worldwide assignments to pharmaceutical, vaccines, cell & gene, start-up, R&D and biotechnology companies.

• 

  Cell medica

  May 2016 - Apr 2017

  Senior director procurement and project management office (ai)

  Defined and implemented the appropriate manufacturing network (CDMOs negotiation, technology transfer, business case for commercial GMP plant, …), involving sites worldwide.Harmonized the procurement processes across sites (5+). Set-up the Project Management Office and led a portfolio of clinical, process development & manufacturing projects. ­

• 

  Idt biologika

  May 2017 - Aug 2018

  Corporate improvement initiative lead (ai)

  Assisted C-level structure with Transformation Programme (Culture change, Performance management, Matrix organisation, S&OP, …). Drove Operational Excellence within manufacturing operations (lean processes & quality). ­Joined the Quality Department to ensure business operations are efficient and effective, while contributing to the CAPA and continuous improvement plans.­Trainer on cGMP principles and facilitator of field workshops.

• 

  Univercells

  Sept 2018 - Sept 2021

  Defined and steered the Strategic Planning. ­Established Project Management Office as a center of excellence. Implemented portfolio governance, best practices in Project Management (milestones tracking, building critical path and mitigating identified critical risks), transversal WoW, New Product/Service Development & Introduction processes (NPDI & NSDI), reporting dashboard, standardized methodologies & tools for planning, executing, staffing, prioritizing, and learning (knowledge repository, training & coaching, resource management). Show less

  • General Manager of Unizima (affiliate)

    May 2020 - Sept 2021

  • Chief Project Officer

    Sept 2018 - Apr 2020
• 

  Sauermann group

  Mar 2022 - Jan 2023

  Group chief operating officer (ai)

  - General Manager of SI Invest S.A.- Member of the Executive Committee

• 

  Q1 scientific belgium

  Feb 2023 - now

  General manager

  Lead Q1 Scientific Belgium which is part of the supply chain process for a number of the world’s largest pharmaceutical companies. Stability storage and testing are critical components of drug development and new therapy commercialisation. Working alongside the expert team, to further solidify the company’s position in Belgium and across Europe.